You are here: Industry Insights > R&D

News List

Where Lies the Competitiveness of China's New Drugs for Central Nervous System? Prof. Zhang
October 18, 2024
The Global Challenges and Opportunities of the R&D of New Drugs for Central Nervous System
Sales volume of Dupixent reaching USD 5.35 billion in H1 of the year, setting off a R&D boom of IL-4R in China PharmaSources/Yefenghong
August 28, 2023
Under the influence of Dupixent, there is a R&D boom of IL-4 targets in China.
35 per 100 CNY Earned for Marketing, How Much is the Sales Expense Ratio of Chinese Pharmaceutical Companies? PharmaSources/Caicai
August 17, 2023
High sales expenses not only increase the cost of medical treatment and medication, but also affect the healthy development of the domestic pharmaceutical industry. Therefore, anti-corruption is imperative and imminent.
AI powers drug R&D OpenAI technology promises a new technological revolution PharmaSources
April 27, 2023
With the development of technology, AI technology has been widely used in several medical field scenarios.
Weekly Pharma News Review | PharmaSources.com (1114-1118) PharmaSources.com
November 21, 2022
The news review of this week is from November 14 to 18, covering a total of 23 pieces of information in 3 sections, i.e., drug review, R&D, and business.
Weekly Pharma News Review | PharmaSources.com (1107-1111) PharmaSources.com
November 14, 2022
The news review of this week is from November 7 to 11, covering a total of 26 pieces of information in 3 sections, i.e., drug review, R&D, and business.
Weekly Pharma News Review | PharmaSources.com (1031-1104) PharmaSources.com
November 08, 2022
The news review of this week is from October 31 to November 4, covering a total of 25 pieces of information in 3 sections, i.e., drug review, R&D, and business.
Weekly Pharma News Review | PharmaSources.com (1024-1028) PharmaSources.com
October 31, 2022
The news review of this week is from October 24 to 28, covering a total of 23 pieces of information in 4 sections, i.e., drug review, R&D, business and listing.
Weekly Pharma News Review | PharmaSources.com (1017-1021) PharmaSources.com
October 24, 2022
The news review of this week is from October 17 to 21, covering a total of 21 pieces of information in 3 sections, i.e., drug review, R&D, and listing.
Weekly Pharma News Review | PharmaSources.com (1008-1014) PharmaSources.com
October 18, 2022
The most exciting thing for the industry is the first-in-class drug, Dorzagliatin Tablets, which is independently researched and developed by Hua Medicine was approved for marketing, becoming the first approved new drug for GKA diabetes in the world.

Previous page 1 2 3 4 5 6 7 Next page